Abstract
To identify new susceptibility loci to lung cancer among diverse populations, we performed cross-ancestry genome-wide association studies in European, East Asian and African populations and discovered five loci that have not been previously reported. We replicated 26 signals and identified 10 new lead associations from previously reported loci. Rare-variant associations tended to be specific to populations, but even common-variant associations influencing smoking behavior, such as those with CHRNA5 and CYP2A6, showed population specificity. Fine-mapping and expression quantitative trait locus colocalization nominated several candidate variants and susceptibility genes such as IRF4 and FUBP1. DNA damage assays of prioritized genes in lung fibroblasts indicated that a subset of these genes, including the pleiotropic gene IRF4, potentially exert effects by promoting endogenous DNA damage.
| Original language | English |
|---|---|
| Pages (from-to) | 1167-1177 |
| Number of pages | 11 |
| Journal | Nature Genetics |
| Volume | 54 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 2022 |
Bibliographical note
Publisher Copyright:© 2022, The Author(s), under exclusive licence to Springer Nature America, Inc.
Funding
Our study was supported by the National Institutes of Health (NIH) for Integrative Analysis of Lung Cancer Etiology and Risk (U19CA203654) and Sequencing Familial Lung Cancer (R01CA243483). C.I.A. is a Research Scholar of the Cancer Prevention Research Interest of Texas (CPRIT) award (RR170048). Functional studies were partially supported by NIH grants (R01CA250905 (S.M.R), CPRIT RR170048 (C.I.A) and DP1-AG072751 (S.M.R.)). This project was supported by the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the CPRIT Core Facility Support Award (CPRIT RP180672) and the NIH (CA125123 and RR024574) as well as the assistance of J.M. Sederstrom. The Resource for the Study of Lung Cancer Epidemiology in North Trent (ReSoLuCENT) study was funded by the Sheffield Hospitals Charity, Sheffield Experimental Cancer Medicine Centre and Weston Park Hospital Cancer Charity. F.T. was supported by a clinical PhD fellowship funded by the Yorkshire Cancer Research/Cancer Research UK Sheffield Cancer Centre. D.M. was supported by Department of Health and Human Services contracts HHSN26820100007C, HHSN268201700012C and 75N92020C00001. J.E.B. was supported by the Intramural Research Program of the National Human Genome Research Institute, NIH. R.W.P. was supported by NIH T32ES027801. J.X. was supported by the National Institute of Environmental Health Sciences of the NIH under Award Number K99ES033259. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH. We acknowledge the participants and investigators of INTEGRAL-ILCCO Consortium, Genetic Epidemiology of Lung Cancer Consortium (GELCC), FinnGen study and Kaiser Permanente Research Bank (KPRB) Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort study. Our study was supported by the National Institutes of Health (NIH) for Integrative Analysis of Lung Cancer Etiology and Risk (U19CA203654) and Sequencing Familial Lung Cancer (R01CA243483). C.I.A. is a Research Scholar of the Cancer Prevention Research Interest of Texas (CPRIT) award (RR170048). Functional studies were partially supported by NIH grants (R01CA250905 (S.M.R), CPRIT RR170048 (C.I.A) and DP1-AG072751 (S.M.R.)). This project was supported by the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the CPRIT Core Facility Support Award (CPRIT RP180672) and the NIH (CA125123 and RR024574) as well as the assistance of J.M. Sederstrom. The Resource for the Study of Lung Cancer Epidemiology in North Trent (ReSoLuCENT) study was funded by the Sheffield Hospitals Charity, Sheffield Experimental Cancer Medicine Centre and Weston Park Hospital Cancer Charity. F.T. was supported by a clinical PhD fellowship funded by the Yorkshire Cancer Research/Cancer Research UK Sheffield Cancer Centre. D.M. was supported by Department of Health and Human Services contracts HHSN26820100007C, HHSN268201700012C and 75N92020C00001. J.E.B. was supported by the Intramural Research Program of the National Human Genome Research Institute, NIH. R.W.P. was supported by NIH T32ES027801. J.X. was supported by the National Institute of Environmental Health Sciences of the NIH under Award Number K99ES033259. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH. We acknowledge the participants and investigators of INTEGRAL-ILCCO Consortium, Genetic Epidemiology of Lung Cancer Consortium (GELCC), FinnGen study and Kaiser Permanente Research Bank (KPRB) Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort study.
| Funders | Funder number |
|---|---|
| FinnGen study and Kaiser Permanente Research Bank | |
| GELCC | |
| KPRB | |
| International Lung Cancer Consortium | |
| Sheffield Experimental Cancer Medicine Centre | |
| Study of Lung Cancer Epidemiology in North Trent | |
| Weston Park Hospital Cancer Charity | |
| Yorkshire Cancer Research/Cancer Research UK Sheffield Cancer Centre | |
| National Institutes of Health (NIH) | RR024574, R01CA243483, CA125123, CPRIT RR170048, CPRIT RP180672, DP1-AG072751 |
| National Institutes of Health (NIH) | |
| U.S. Department of Health and Human Services | HHSN268201700012C, 75N92020C00001, HHSN26820100007C |
| U.S. Department of Health and Human Services | |
| National Human Genome Research Institute | T32ES027801 |
| National Human Genome Research Institute | |
| National Childhood Cancer Registry – National Cancer Institute | R01CA250905, U19CA203654, ZIACP010201 |
| National Childhood Cancer Registry – National Cancer Institute | |
| National Institutes of Health/National Institute of Environmental Health Sciences | K99ES033259 |
| National Institutes of Health/National Institute of Environmental Health Sciences | |
| Cancer Prevention and Research Institute of Texas | |
| National Cancer Institute Division of Cancer Epidemiology and Genetics | |
| Sheffield Hospitals Charity |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Genetics
Fingerprint
Dive into the research topics of 'Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver